
---
title: '双成药业：依替巴肽注射液sANDA获得美国FDA上市许可'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=8266'
author: 证券时报网
comments: false
date: Thu, 21 Apr 2022 18:56:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=8266'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ002693" style="color: #2f67d1;text-decoration: none;" code="002693" target="_blank">双成药业</a>(002693)4月21日晚间公告，公司依替巴肽注射液（75mg/100mL）sANDA通过美国FDA上市许可批准。</p>

                  
</div>
            